Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

Tony Coelho Discusses Patient Care with Former HHS Secretary
February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

 | Read More
PCORI Releases their Draft Priorities
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

 | Read More
Differentiating Patients, Consumers, and Patient Advocacy Organizations
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

 | Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

June 2009

PIPC Calls for Bipartisan Consensus on Patient-Centered Comparative Effectiveness

WASHINGTON, June 26, 2009 – After speaking at a health care reform event on comparative effectiveness research and choice in health care, Chairman of the Partnership to Improve Patient Care (PIPC), Tony Coelho, issued the following statement:
 

Why is CER Important?

Submitted by Tony Coelho on Tue, 06/23/2009 - 22:50 | Posted in:

On Thursday, I will be joining the Alliance for Health Reform to participate in a panel discussion about choices can affect healthcare and how comparative effectiveness research (CER) should be considered by policymakers considering healthcare reform legislation.
 

Welcome to new PIPC Website

Submitted by Tony Coelho on Thu, 06/18/2009 - 22:43 | Posted in:

Welcome to PIPC. We're a broad coalition dedicated to promoting patient-centered approaches to comparative effectiveness research (CER).

You may have been hearing about comparative effectiveness research as part of the current health care debate going on here in Washington. We believe CER can benefit patients by giving them the information they need to make good health care decisions, and we're working hard to make sure CER is focused on the needs of patients and caregivers.

ALLHAT Case Study

ALLHAT Case STudy

In December of 2002, the National Institutes of Health (NIH) published a study in the Journal of the American Medical Association (JAMA) that sought to compare the relative benefits of three popular hypertension medicines. The study known by its abbreviated title, ALLHAT, garnered significant media attention because of its large sample size, government sponsorship, and seemingly novel results. While the majority of media reports on the study contained accurate information, the study‚ outcomes and implications were over-simplified and over-interpreted.